Alteraciones electrocardiográficas inducidas por paclitaxel (taxol)

Gerson, Raquel; Serrano, Alberto; Osorio B., Julio; Rojas, José A; Espinoza, Rafael; Villalobos, Alberto; Solana, Sergio; Sánchez Forgach, Ernesto; Montes de Oca, José; Pulido, Tomás; Baduí, Elías.
Rev. Inst. Nac. Cancerol. (Méx.) ; 43(1): 34-9, ene.-mar. 1997. tab, ilus
Artículo en Español | LILACS | ID: lil-219752

Documentos relacionados

  1. [Radiation-Induced Heart Disease: Current Status and Challenges].
  2. Radiation-Induced Cardiac Dysfunction: Optimizing Radiation Delivery and Postradiation Care.
  3. Targeting Microtubules for the Treatment of Heart Disease.
  4. Multi-chamber cardioids unravel human heart development and cardiac defects.
  5. Cardio-Onco-Metabolism - Metabolic vulnerabilities in cancer and the heart.
  6. Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study.
  7. A big data scheme for heart disease classification in map reduce using jellyfish search flow regime optimization enabled Spinalnet.
  8. How I treat cardiovascular complications in patients with lymphoid malignancies.
  9. <i>In Cellulo</i> Bioorthogonal Catalysis by Encapsulated <b>AuPd</b> Nanoalloys: Overcoming Intracellular Deactivation.
  10. Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer.